GlassScriptPhysician profile
Amy Eastman
NPI 1487858304
$917.35
in general payments reported to CMS, 2019-2025
23 companies · $363 in 2025
The $363 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.38 · 2020: $15.21 · 2022: $99.95 · 2023: $136 · 2024: $278 · 2025: $363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $777.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $776.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $219.47 | 2024-2025 | Molli, Optablate |
| Tactile Systems Technology INC | $86.46 | 2022-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Novartis Pharmaceuticals Corporation | $82.56 | 2025 | |
| Pfizer INC. | $59.37 | 2025 | |
| Incyte Corporation | $51.11 | 2023-2024 | Jakafi, Monjuvi |
| Daiichi Sankyo INC. | $49.54 | 2025 | Datroway |
| Janssen Biotech, INC. | $37.14 | 2024 | Rybrevant |
| Innovation Technologies INC | $36.94 | 2023 | Irrisept |
| Iovance Biotherapeutics, INC. | $32.40 | 2025 | Amtagvi |
| Alnylam Pharmaceuticals INC. | $27.50 | 2025 | Givlaari |
| Davol INC. | $25.38 | 2019 | |
| Morphosys, US INC. | $22.61 | 2023 | Monjuvi |
| Boston Scientific Corporation | $20.76 | 2023 | Wavewriter Alpha Prime 16 |
| Jazz Pharmaceuticals INC. | $20.27 | 2022 | |
| Tempus Ai, INC | $19.64 | 2025 | Xt Cdx |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eusa Pharma (US) LLC | $19.26 | 2022 | |
| Sobi, INC | $17.97 | 2025 | |
| Emmaus Medical, INC. | $16.80 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $15.84 | 2022 | |
| Merit Medical Systems INC | $15.21 | 2020 | |
| Hologic Sales and Service, LLC | $14.08 | 2023 | Localizer |
| Takeda Pharmaceuticals U.S.A., INC. | $14.07 | 2023 | Ninlaro |
| Lilly USA, LLC | $12.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Eastman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.